Eddy Pasquier Selected Research

Eddy Pasquier Research Topics

Disease

36	Neoplasms (Cancer) 08/2022 - 10/2004
6	Neuroblastoma 01/2017 - 10/2013
5	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2007
5	Neoplasm Metastasis (Metastasis) 04/2014 - 10/2004
4	Hemangiosarcoma (Angiosarcoma) 04/2016 - 01/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 10/2007
3	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 02/2009
2	Glioma (Gliomas) 11/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2014
2	Triple Negative Breast Neoplasms 12/2014 - 10/2011
1	Medulloblastoma 08/2022
1	Carcinogenesis 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Rhabdomyosarcoma 10/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hypotrichosis 01/2019
1	Telangiectasis (Telangiectasia) 01/2019
1	Edema (Dropsy) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Hemangioma (Angioma) 01/2019
1	Lymphedema (Milroy Disease) 01/2019
1	Vascular Neoplasms (Neoplasms, Vascular) 01/2019
1	Malignant Mesothelioma 03/2018
1	Inflammation (Inflammations) 01/2017
1	Adenocarcinoma 11/2015
1	Disease Resistance 07/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2011
1	Multiple Myeloma 05/2010
1	Meningeal Carcinomatosis 08/2009
1	Subdural Hematoma (Subdural Hemorrhage) 08/2009
1	Anemia 07/2008
1	Neutropenia 07/2008

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 08/2022 - 08/2010
6	Propranolol (Inderal)FDA LinkGeneric 01/2019 - 10/2011
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2013 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2016
3	Drug CombinationsIBA 01/2019 - 10/2011
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2016 - 02/2011
2	beta Adrenergic ReceptorsIBA 08/2022 - 01/2019
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2022 - 04/2016
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2017
2	Gemcitabine FDA Link 11/2020 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 04/2016 - 01/2011
2	Long Noncoding RNAIBA 02/2016 - 04/2014
2	Hormones (Hormone)IBA 11/2015 - 05/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 09/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 07/2008
2	TubulinIBA 10/2007 - 09/2007
1	Superoxides (Superoxide)IBA 08/2022
1	Histones (Histone)IBA 11/2021
1	Mitogen-Activated Protein Kinase 14IBA 12/2020
1	Mebendazole (Anti-Worm)FDA Link 12/2020
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 11/2020
1	Phenformin (Fenformin)IBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	CaspasesIBA 01/2019
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2019
1	SOXF Transcription FactorsIBA 01/2019
1	PolyphenolsIBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	CopperIBA 01/2017
1	Catechin (Z 7300)IBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2016
1	ImmunosorbentsIBA 02/2016
1	Small Interfering RNA (siRNA)IBA 02/2016
1	Conditioned Culture MediaIBA 02/2016
1	EnzymesIBA 02/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Mannich BasesIBA 11/2015
1	phenoxodiolIBA 11/2015
1	Biological ProductsIBA 11/2015
1	IsoflavonesIBA 11/2015
1	daidzeinIBA 11/2015
1	SaltsIBA 10/2014
1	Fluorouracil (Carac)FDA LinkGeneric 04/2013
1	LuciferasesIBA 10/2011
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	2- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA 05/2010
1	2-MethoxyestradiolIBA 05/2010
1	AndrogensIBA 02/2009
1	Etoposide (VP 16)FDA LinkGeneric 07/2008
1	Celecoxib (Celebrex)FDA Link 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	A-Form DNA (A-DNA)IBA 10/2007

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 11/2021 - 02/2006
17	Therapeutics 08/2022 - 03/2006
1	Radiotherapy 08/2022
1	Aftercare (After-Treatment) 01/2017
1	Biological Therapy 12/2015
1	Immunotherapy 12/2015
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015
1	Erythrocyte Transfusion 07/2008